Tang, Peng |
NCT04848753: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Active, not recruiting | 3 | 663 | RoW | Toripalimab combined with cisplatin and paclitaxel, Placebo combined with cisplatin and paclitaxel | Shanghai Junshi Bioscience Co., Ltd. | Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | 05/27 | 05/27 | | |
NCT05476380: Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 39 | RoW | camrelizumab, Paclitaxel, Cisplatin | Tianjin Medical University Cancer Institute and Hospital | Esophageal Carcinoma | 12/22 | 12/24 | | |
NCT05637268: Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 23 | RoW | Camrelizumab, Suzhou Shengdia Biological Medicine Co., LTD, Paclitaxel, Cisplatin | Tianjin Medical University Cancer Institute and Hospital | Esophagus Cancer | 06/24 | 06/25 | | |
NCT06637163: Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC |
|
|
| Not yet recruiting | 2 | 100 | RoW | Benmelstobart+ Paclitaxel + Carboplatin+ Radiotherapy, Paclitaxel + Carboplatin + Radiotherapy | Shanghai Zhongshan Hospital | Esophageal Squamous Cell Carcinoma | 04/26 | 04/27 | | |
NCT05260385: To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors |
|
|
| Recruiting | 1/2 | 133 | RoW | KC1036 | Beijing Konruns Pharmaceutical Co., Ltd. | Digestive System Tumors | 10/25 | 12/25 | | |
| Recruiting | N/A | 400 | RoW | Goal-directed EN therapy, Conventional EN therapy | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Esophagus Cancer | 08/26 | 05/31 | | |
NCT05443841: Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005) |
|
|
| Recruiting | N/A | 385 | RoW | pleural lavage | Fudan University | Esophageal Cancer | 07/24 | 07/27 | | |
NCT05812495: Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side Anastomosis |
|
|
| Recruiting | N/A | 402 | RoW | Esophagogastric Side to Side Anastomosis, Esophagogastric End to Side Anastomosis | Tianjin Medical University Cancer Institute and Hospital | Epiphora Due to Insufficient Drainage, Left Side, Epiphora Due to Insufficient Drainage, Right Side | 12/24 | 12/24 | | |